Taken together, these studies across diverse models have delineated potential mechanisms underlying AXL-mediated immunosuppression, including reduced tumor antigen presentation, attenuated pro-inflammatory cytokine cascades, disrupted immune cell infiltration and increase immune checkpoint expression. The gene discussed is AXL; the disease is neoplasm.